BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22108051)

  • 21. Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.
    Sakai Y; Okumura H; Iwao T; Watashi K; Ito K; Matsunaga T
    Toxicol In Vitro; 2019 Dec; 61():104619. PubMed ID: 31394163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
    Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
    Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport.
    Wolf KK; Vora S; Webster LO; Generaux GT; Polli JW; Brouwer KL
    Toxicol In Vitro; 2010 Feb; 24(1):297-309. PubMed ID: 19706322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.
    Yang K; Guo C; Woodhead JL; St Claire RL; Watkins PB; Siler SQ; Howell BA; Brouwer KLR
    J Pharm Sci; 2016 Feb; 105(2):443-459. PubMed ID: 26869411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic-Induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition.
    Li Y; Hafey MJ; Duong H; Evers R; Cheon K; Holder DJ; Galijatovic-Idrizbegovic A; Sistare FD; Glaab WE
    Toxicol Sci; 2017 May; 157(1):30-40. PubMed ID: 28108666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
    Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
    Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats.
    Slopianka M; Herrmann A; Pavkovic M; Ellinger-Ziegelbauer H; Ernst R; Mally A; Keck M; Riefke B
    Toxicology; 2017 Jul; 386():1-10. PubMed ID: 28529062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).
    Pedersen JM; Matsson P; Bergström CA; Hoogstraate J; Norén A; LeCluyse EL; Artursson P
    Toxicol Sci; 2013 Dec; 136(2):328-43. PubMed ID: 24014644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery.
    Hafey MJ; Houle R; Tanis KQ; Knemeyer I; Shang J; Chen Q; Baudy A; Monroe J; Sistare FD; Evers R
    Drug Metab Dispos; 2020 Nov; 48(11):1147-1160. PubMed ID: 32943412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition.
    Cepa S; Potter D; Wong L; Schutt L; Tarrant J; Pang J; Zhang X; Andaya R; Salphati L; Ran Y; An L; Morgan R; Maher J
    Toxicol Appl Pharmacol; 2018 Jan; 338():204-213. PubMed ID: 29146462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury.
    Yang K; Pfeifer ND; Köck K; Brouwer KL
    J Pharmacol Exp Ther; 2015 May; 353(2):415-23. PubMed ID: 25711339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
    Ali I; Khalid S; Stieger B; Brouwer KLR
    Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.
    Welch MA; Köck K; Urban TJ; Brouwer KL; Swaan PW
    Drug Metab Dispos; 2015 May; 43(5):725-34. PubMed ID: 25735837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.
    Kostrubsky SE; Strom SC; Kalgutkar AS; Kulkarni S; Atherton J; Mireles R; Feng B; Kubik R; Hanson J; Urda E; Mutlib AE
    Toxicol Sci; 2006 Apr; 90(2):451-9. PubMed ID: 16410371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a Bile Salt Export Pump Knockdown Rat Susceptibility Model to Interrogate Mechanism of Drug-Induced Liver Toxicity.
    Li Y; Evers R; Hafey MJ; Cheon K; Duong H; Lynch D; LaFranco-Scheuch L; Pacchione S; Tamburino AM; Tanis KQ; Geddes K; Holder D; Zhang NR; Kang W; Gonzalez RJ; Galijatovic-Idrizbegovic A; Pearson KM; Lebron JA; Glaab WE; Sistare FD
    Toxicol Sci; 2019 Jul; 170(1):180-198. PubMed ID: 30903168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats.
    Yamazaki M; Miyake M; Sato H; Masutomi N; Tsutsui N; Adam KP; Alexander DC; Lawton KA; Milburn MV; Ryals JA; Wulff JE; Guo L
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):79-89. PubMed ID: 23360887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function and Expression of Bile Salt Export Pump in Suspension Human Hepatocytes.
    Chothe PP; Pemberton R; Hariparsad N
    Drug Metab Dispos; 2021 Apr; 49(4):314-321. PubMed ID: 33472814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
    Jackson JP; Brouwer KR
    Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats.
    Yang F; Takeuchi T; Tsuneyama K; Yokoi T; Oda S
    Toxicol Sci; 2019 Jul; 170(1):95-108. PubMed ID: 30985903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.